Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Other Non-Current Assets data on file, last reported at $203000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 99.1% year-over-year to $203000.0 in Q1 2026; TTM through Mar 2026 was $203000.0, a 99.1% decrease from a year earlier, with the FY2025 full-year figure at $206000.0, down 99.09% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $203000.0, down from $206000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for DTIL reached as high as $26.3 million in Q3 2025 and fell as low as $203000.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $9.1 million across 5 years, with a median of $3.7 million in 2022.
• Across the five-year window, Other Non-Current Assets surged 9930.67% in 2024 and slumped 99.1% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.6 million in 2022, then tumbled by 85.54% to $225000.0 in 2023, then jumped by 9930.67% to $22.6 million in 2024, then slumped by 99.09% to $206000.0 in 2025, then retreated by 1.46% to $203000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $203000.0 in Q1 2026, $206000.0 in Q4 2025, and $26.3 million in Q3 2025.